Emerging Collaboration in EU Drug Pricing and Reimbursement Table 2

Four tips for midsized companies when entering new global markets.

The pharmaceutical company had previously been subjected to a 2-year suspension.

Pharma companies face unique challenges with market access in this region.

Three of the new sites will focus primarily on producing ingredients for domestic usage.

Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical.

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.